- Home
- INMB vs FTK Comparison
INMB vs FTK Comparison
Compare INMB & FTK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- INMB
- FTK
- Stock Information
- Founded
- INMB 2015
- FTK 1985
- Country
- INMB United States
- FTK United States
- Employees
- INMB N/A
- FTK N/A
- Industry
- INMB Biotechnology: Pharmaceutical Preparations
- FTK Major Chemicals
- Sector
- INMB Health Care
- FTK Industrials
- Exchange
- INMB Nasdaq
- FTK Nasdaq
- Market Cap
- INMB 123.0M
- FTK 123.1M
- IPO Year
- INMB 2019
- FTK N/A
- Fundamental
- Price
- INMB $4.83
- FTK $4.87
- Analyst Decision
- INMB Buy
- FTK Strong Buy
- Analyst Count
- INMB 1
- FTK 2
- Target Price
- INMB $22.00
- FTK $6.75
- AVG Volume (30 Days)
- INMB 261.5K
- FTK 152.5K
- Earning Date
- INMB 10-30-2024
- FTK 11-04-2024
- Dividend Yield
- INMB N/A
- FTK N/A
- EPS Growth
- INMB N/A
- FTK N/A
- EPS
- INMB N/A
- FTK 0.24
- Revenue
- INMB $85,000.00
- FTK $175,982,000.00
- Revenue This Year
- INMB N/A
- FTK $0.33
- Revenue Next Year
- INMB N/A
- FTK $11.86
- P/E Ratio
- INMB N/A
- FTK $20.23
- Revenue Growth
- INMB N/A
- FTK N/A
- 52 Week Low
- INMB $4.78
- FTK $2.64
- 52 Week High
- INMB $14.74
- FTK $5.61
- Technical
- Relative Strength Index (RSI)
- INMB 35.56
- FTK 51.64
- Support Level
- INMB $4.87
- FTK $4.75
- Resistance Level
- INMB $5.23
- FTK $5.15
- Average True Range (ATR)
- INMB 0.29
- FTK 0.24
- MACD
- INMB 0.03
- FTK -0.03
- Stochastic Oscillator
- INMB 5.18
- FTK 51.61
About INMB INmune Bio Inc. Common stock
INmune Bio Inc is a clinical-stage biotechnology company. It is engaged in the development of new immunotherapies that reprogram a patient's innate immune system to allow immune system to fight cancer. The company's pipeline products includeINKmune, INBO3, XPro1595, LIVNate, and others.
About FTK Flotek Industries Inc.
Flotek Industries Inc is a technology-driven company focused on reducing the environmental impact of energy operations. Its Chemistry Technologies segment develops green specialty chemicals to enhance the profitability of hydrocarbon producers, catering to major players in the oil and gas industry. These chemicals improve operational efficiency and sustainability throughout the well life cycle. The Data Analytics segment provides real-time analytics for hydrocarbon streams, enabling users to optimize processes and increase profitability by reducing waste and reprocessing. Flotek's revenue primarily comes from its Chemistry segment, reflecting its commitment to providing solutions for environmental improvement in the energy sector.